Interlaboratory Performance of a Microarray-Based Gene Expression Test to Determine Tissue of Origin in Poorly Differentiated and Undifferentiated Cancers
- 31 January 2008
- journal article
- Published by Elsevier BV in The Journal of Molecular Diagnostics
- Vol. 10 (1), 67-77
- https://doi.org/10.2353/jmoldx.2008.070099
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Robust interlaboratory reproducibility of a gene expression signature measurement consistent with the needs of a new generation of diagnostic toolsBMC Genomics, 2007
- Using RNA sample titrations to assess microarray platform performance and normalization techniquesNature Biotechnology, 2006
- The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurementsNature Biotechnology, 2006
- Evaluation of DNA microarray results with quantitative gene expression platformsNature Biotechnology, 2006
- Concordance among Gene-Expression–Based Predictors for Breast CancerNew England Journal of Medicine, 2006
- Microarray reality checks in the context of a complex diseaseNature Biotechnology, 2004
- Evaluation of gene expression measurements from commercial microarray platformsNucleic Acids Research, 2003
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- A Coefficient of Agreement for Nominal ScalesEducational and Psychological Measurement, 1960